Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News InnoCan Pharma Corporation C.INNO

Alternate Symbol(s):  INNPF

Healthcare Drug Manufacturers - Specialty & Generic
InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company operates in two segments: Online Sales and Other Operations. It engages in the research and development of CBD loaded exosomes, as... see more

Recent & Breaking News (CSE:INNO)

Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering

Canada NewsWire 3 days ago

Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M

Canada NewsWire November 27, 2025

Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats

Canada NewsWire November 24, 2025

Innocan Pharma announces promising results of LPT-CBD administered to Gottingen Minipigs, a well-known drug toxicology model

Canada NewsWire November 20, 2025

CSE Bulletin: MOC Eligibility Update

Newsfile November 14, 2025

Innocan Pharma to Present at the 2025 ThinkEquity Conference

Canada NewsWire October 24, 2025

Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan

Canada NewsWire October 15, 2025

Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection

Canada NewsWire September 18, 2025

Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference

Canada NewsWire September 15, 2025

CSE Bulletin: Consolidation - InnoCan Pharma Corporation (INNO)

Newsfile September 2, 2025

Innocan Pharma Announces Details of Proposed Share Consolidation

Canada NewsWire August 29, 2025

Innocan Pharma Announces First Half Of 2025 Financial Results

Canada NewsWire August 27, 2025

Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada

Canada NewsWire August 22, 2025

Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering

Canada NewsWire July 23, 2025

Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, providing a good translational model and Provides Corporate Update

Canada NewsWire July 3, 2025

Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference

Canada NewsWire June 20, 2025

Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach

Canada NewsWire June 13, 2025

Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update

Canada NewsWire May 28, 2025

Innocan secures Mexican patent for topical pain-relief technology

Jonathon Brown May 6, 2025

Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief

Canada NewsWire May 6, 2025